Treatment-Resistant Depression Part B

1st Edition, Volume 281 - September 26, 2023
Editors: Chih-Ming Cheng, Cheng-Ta Li
Language: English
Hardback ISBN:
9 7 8 - 0 - 4 4 3 - 2 2 3 9 4 - 5
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 2 2 3 9 5 - 2

Treatment-Resistant Depression, Part B, Volume 281 in the Progress in Brain Research series, highlights new advances in the field, with this new volume presenting interesting chap… Read more

Purchase options

Limited Offer

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Treatment-Resistant Depression, Part B, Volume 281 in the Progress in Brain Research series, highlights new advances in the field, with this new volume presenting interesting chapters on highly relevant topics such as Treatment Resistant Depression in Children and Adolescents, Treatment Resistant Depression in Elderly, Brain Stimulation for Treatment Resistant Depression, Electroconvulsive Therapy for Treatment Resistant Depression, Psychological aspects and Psychotherapy for Treatment Resistant Depression, Psychiatric Rehabilitation and Cognitive Deficit for Treatment-Resistant Depression, Insomnia and Treatment Resistant Depression, and Tinnitus and Treatment Resistant Depression.

Cover image
Title page
Table of Contents
Series Page
Copyright
Contributors
Preface
Chapter 1: Treatment-resistant depression in children and adolescents
Abstract
1: Depression in children and adolescents
2: Treatment for major depressive disorder
3: Definition of treatment-resistant depression
4: Prevalence of treatment-resistant depression and clinical significance
5: Risk factors associated with treatment-resistant depression
6: Pharmacotherapy
7: Psychotherapy
8: Neuromodulation
9: Complementary alternative medicine
10: Combination treatment
11: Conclusion
References
Chapter 2: Treatment resistant depression in elderly
Abstract
1: Introduction
2: Pathogenesis
3: Diagnostic challenges: A multidimensional approach
4: Treatment overview
5: Pharmacological treatment
6: Nonpharmacological treatment
7: Conclusion
References
Chapter 3: Brain stimulation for treatment-resistant depression
Abstract
1: Introduction
2: Non-invasive brain stimulation interventions
References
Further reading
Chapter 4: Electroconvulsive therapy for treatment-resistant depression
Abstract
1: Introduction
2: Position of ECT in the definition of TRD
3: Position of ECT as the solution for TRD
4: Position of ECT among neurostimulation treatments for depression
5: Predictors of ECT response/poor response in patients with depression
6: The Global ECT-MRI Research Collaboration and other international collaboration
7: Mechanisms of ECT in depression
8: Cognitive side effects and novel methodology to reduce the problem
9: Conclusion
References
Chapter 5: Psychiatric rehabilitation and cognitive deficit for treatment-resistant depression
Abstract
1: Introduction: Psychiatric rehabilitation concepts in treatment-resistant depression
2: Cognitive decline in major depressive disorder and difficulty resuming normal life
3: Potential treatments for cognitive dysfunction in MDD
4: Multidisciplinary team for rehabilitation and functional recovery
5: Summary
Acknowledgement
References
Chapter 6: Insomnia and treatment-resistant depression
Abstract
1: Introduction
2: Relationship between sleep and major depressive disorder
3: Theories related to the association of sleep disturbance and depression
4: Sleep and treatment-resistant depression
5: Treatment of sleep disturbance in depression patients
6: Conclusion
References
Chapter 7: Tinnitus and treatment-resistant depression
Abstract
1: Introduction
2: Tinnitus and its neuronal mechanisms
3: Depression and treatment resistant depression
4: The interplay of tinnitus and depression
5: Conclusion
References
Chapter 8: Migraine and treatment-resistant depression
Abstract
1: Background
2: Epidemiology
3: Impact
4: Mechanisms
5: Treatment
6: Conclusion
References

Chih-Ming Cheng

Dr. Chih-Ming Cheng received his psychiatric residency training and geriatric psychiatry fellowship at Taipei Veterans General Hospital(VGHTPE), Taiwan. After training, he became an attending psychiatrist in the YuanShan branch of VGHTPE and then back to VGHTPE in 2020. In academic research, he followed Prof. Cheng-Ta Li, Prof. Tung-Ping Su, and Prof. Ya-Mei Bai in the field of neuromodulation, neuroinflammation, functional neuroimaging and new antidepressant clinical trials, and Dr. Mu-Hong Chen in the field of ketamine and epidemiologic studies. His research interests are brain stimulation and epidemiology in psychiatric disorders, especially major depressive disorders. He now investigates trans-diagnostic heredity and excess mortality of psychiatric disorders and the heredity and treatment characteristics of treatment-resistant major depressive disorders by using the Taiwan national health insurance registry database, as well as the efficacy of rTMS/iTBS intervention in treatment-resistant depressed patients. He is also one of the committee experts for brain electromagnetic stimulation and treatment, Taiwan Society of Biological Psychiatry and Neuropsychopharmacology(TSBPN) and the TSBPN Working group for renewing Taiwan's recommendation of pharmacological treatment for bipolar disorder. Dr. Cheng has published about sixty peer-reviewed articles, including publications in Molecular Psychiatry, Neurology, Psychological Medicine, Psychiatry and clinical neurosciences, Allergy, and Psychiatry Research..etc.

Affiliations and expertise

Attending Psychiatrist, Division of Community and Rehabilitation Psychiatry, Taipei Veterans General Hospital, Taiwan

Cheng-Ta Li

Cheng-Ta Li is a professor at National Yang Ming Chiao Tung University and is a division chief at Taipei Veterans General Hospital. Professor Li has been devoted in the field of TRD for over 15 years. Now, he is ranked top <1% in the field of TRD with multi-disciplinary collaborations. Based on the result of Expertscape (2011-2021), he is currently ranked #< 1% (0.77%) in the world in the field of TRD and is the highest among scientists in Taiwan. This book, inviting internationally renowned experts in the field, aims to clarify unsettled issues related to TRD, to provide a better understanding about TRD, and to improve treatment efficacy for TRD.

Affiliations and expertise

Professor, National Yang Ming Chiao Tung University; Division chief, Taipei Veterans General Hospital, Taiwan